Skip to main content

and
  1. Chapter

    Off-the-Shelf Allogeneic CAR-T Cells or Other Immune Effector Cells

    “Off-the-shelf” allogeneic CAR TCRab T cells and other immune effector cells, such as natural killer (NK) or gamma delta (gd) T cells, can be premanufactured from healthy donors and may offer alternatives to a...

    Stephane Depil, Waseem Qasim in The EBMT/EHA CAR-T Cell Handbook (2022)

  2. Article

    Open Access

    Base-edited CAR T cells for combinational therapy against T cell malignancies

    Targeting T cell malignancies using chimeric antigen receptor (CAR) T cells is hindered by ‘T v T’ fratricide against shared antigens such as CD3 and CD7. Base editing offers the possibility of seamless disrup...

    Christos Georgiadis, Jane Rasaiyaah, Soragia Athina Gkazi, Roland Preece in Leukemia (2021)

  3. No Access

    Article

    Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency

    Zohreh Nademi, Robert F. Wynn, Mary Slatter in Bone Marrow Transplantation (2019)

  4. No Access

    Article

    Gene Therapy for Primary Immunodeficiencies: Current Status and Future Prospects

    Gene therapy using autologous haematopoietic stem cells offers a valuable treatment option for patients with primary immunodeficiencies who do not have access to an HLA-matched donor, although such treatments ...

    Waseem Qasim, Andrew R. Gennery in Drugs (2014)